13 Dec 2017 --- Frutarom has acquired AB-Fortis activities, including a patent-protected micro-encapsulation technology that enables delivery of iron with increased biological absorption. Frutarom announced the signing of an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis in November.
AB-Fortis is an advanced encapsulated iron system for delivering the recommended daily amount of iron in a single dose. It helps consumers avoid the common negative aspects and side effects of iron supplements, including metallic aftertaste, dental darkening, gastrointestinal upset and nausea. AB-Fortis iron can be incorporated into fat-rich matrices, such as milk or yogurt, without causing oxidation. It is heat- and pH-stable. It will not accelerate oxidation of other components of a formulation, such as folate or omega 3 fatty acids. This makes it ideal for functional foods, infant nutrition and food supplements.
Frutarom acquired the technology and expanded its activity in the market after four years of experience developing applications in a wide range of food and beverage products.
“Iron’s high reactivity commonly leads to negative side effects when relevant dosages are ingested,” notes Wouter Haazen, Product Manager for Frutarom Health. “AB-Fortis is produced using a patented process, which provides highly stable encapsulation ensuring no release of free iron in the food matrix. In addition, it has a high concentration of iron (40 percent). Coating the iron using AB-Fortis’ unique micro-encapsulation technology stabilizes and protects it, rendering the iron flavorless and allowing for adequate dosages, all without the negative side effects, while maintaining a high bioavailability.”
“AB-Fortis expands Frutarom’s diverse product portfolio in the growing field of specialty healthy ingredients,” says Dr. Raimund C. Hoenes, General Manager of Frutarom Health. “Delivering iron supplementation in a safe, highly bioavailable and palatable form is an important objective for many of our food and supplement customers. We work closely with them to bring innovative solutions that combine our core competencies.”
09 Apr 2018 –
Novartis has entered into an agreement and plan ...
27 Mar 2018 –
GlaxoSmithKline (GSK) has reached an agreement ...
16 Mar 2018 –
A US$70 million investment in a new ...
12 Mar 2018 –
Ancient Nutrition, a bone broth protein and ...
06 Feb 2018 –
French microalgae supplier Fermentalg has ...